Woodstock Sterile Solutions
United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
✓ HC GMP (1)
Quick Facts: Woodstock Sterile Solutions
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- United States
- Website
- https://woodstocksterilesolutions.com/
- Modalities
- Sterile Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Woodstock Sterile Solutions
Woodstock Sterile Solutions is a contract development and manufacturing organization (CDMO). Capabilities: Sterile Fill-Finish. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://woodstocksterilesolutions.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Woodstock Sterile Solutions FDA Inspection History
2022-10
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2022-10-13 |
Woodstock Sterile Solutions Inc
Woodstock, Illinois
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 8 articles
Company announcements, not verified evidence. They do not change any score.
SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions - Contract Pharma
Woodstock Sterile Solutions Completes Analytical Lab Expansion - Contract Pharma
Emergent BioSolutions appoints new executives to leadership team - The Business Journals
New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO - Fierce Pharma
Leading with Precision: Nick Buschur on Driving Growth and Innovation at Woodstock Sterile Solutions - Contract Pharma
After its breakout from Catalent, Woodstock Sterile Solutions emerges as a CDMO solo act - Fierce Pharma
Considering Blow-Fill-Seal for Biologic Drugs - BioPharm International
Parenteral and Sterile Fill-Finish Development and Manufacturing Trends - Contract Pharma
Frequently Asked Questions About Woodstock Sterile Solutions
How many FDA inspections does Woodstock Sterile Solutions have on record?
CDMO Signal tracks 1 FDA inspection for Woodstock Sterile Solutions, sourced from the FDA inspection database. See the full inspection history above.
Has Woodstock Sterile Solutions received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Woodstock Sterile Solutions.
Does Woodstock Sterile Solutions have a CDMO Signal Score?
Not yet. Woodstock Sterile Solutions is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Woodstock Sterile Solutions for a manufacturing program?
Use the free AI matchmaker to compare Woodstock Sterile Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
DPT Laboratories
San Antonio, Texas, United States
Semi-solids & Liquids, Non-sterile Liquids, Topicals, Finished Dosage Forms, Sterile Fill-Finish, Clinical Trial Manufacturing
Sharp Services
United States
Packaging & Labeling, Sterile Fill-Finish
Vetio Animal Health
United States
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
503 Neo Lab (NeoLabs Pharma)
United States
Sterile Fill-Finish
Alcami Carolinas
United States
Oral Solid Dose, Sterile Fill-Finish, Small Molecule API
Compare Woodstock Sterile Solutions with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.